C. Brunstein

发表

Double umbilical cord blood transplantation.

J. Wagner, N. Majhail, C. Brunstein, 2006, Current opinion in immunology.

Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation.

J. Wagner, D. Weisdorf, A. Blaes, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.

J. Wagner, Jeffrey S. Miller, M. Verneris, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning.

J. Wagner, M. Kirstein, D. Weisdorf, 2016, Translational research : the journal of laboratory and clinical medicine.

Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials.

J. Wagner, B. Levine, C. June, 2017, Cytotherapy.

Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia.

D. Weisdorf, B. Oran, Q. Cao, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Novel cord blood transplant therapies.

E. Shpall, C. Bollard, C. Brunstein, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.

D. Weisdorf, E. Gluckman, V. Rocha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.

D. Kaufman, J. Wagner, K. Dusenbery, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors and outcomes of flares in chronic graft-versus-host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2022, Bone Marrow Transplantation.

Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplant Recipients.

S. Bhatia, D. Weisdorf, M. Arora, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia.

K. Ballen, L. Metheny, A. Rezvani, 2021, Transplantation and cellular therapy.

Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndromes Patients ≥70 Years Old

M. Arora, N. Bejanyan, T. DeFor, 2016 .

Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years.

D. Weisdorf, M. Arora, N. Bejanyan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.

S. Montoto, M. Perales, I. Yakoub-Agha, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant.

K. Ballen, O. Ringdén, D. Rizzieri, 2020, Biology of Blood and Marrow Transplantation.

Matching at HLA-C improved the outcomes after double umbilical cord blood transplantation for recipients of 2–4/6 HLA-matched grafts

J. Wagner, K. Ballen, R. Soiffer, 2017 .

Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation.

D. Weisdorf, V. Bachanova, L. Burns, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation.

J. Wagner, Jeffrey S. Miller, B. Blazar, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR

S. Montoto, Sonali M. Smith, D. Maloney, 2014, Bone Marrow Transplantation.

Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood

A. Nagler, M. Mohty, D. Niederwieser, 2014, Haematologica.

Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma

D. Weisdorf, V. Bachanova, J. Miller, 2009, Bone Marrow Transplantation.

Surveillance imaging after autologous hematopoietic cell transplantation predicts survival in patients with diffuse large B cell lymphoma.

D. Weisdorf, V. Bachanova, Z. Cayci, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome.

D. Weisdorf, V. Bachanova, L. Burns, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical cord blood transplantation for the treatment of hematologic malignancies.

C. Brunstein, 2011, Cancer control : journal of the Moffitt Cancer Center.

BEAM Conditioning Is Well Tolerated and Yields Similar Survival in Obese and Non-Obese Patients with Lymphoma: No Requirement for Weight-Based Dose Modifications

V. Bachanova, R. Shanley, C. Brunstein, 2016, Bone Marrow Transplantation.

The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples.

Jeffrey S. Miller, D. Weisdorf, A. Rashidi, 2019, Blood advances.

Risk of Relapse (REL) after Umbilical Cord Blood Transplantation (UCBT) in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2005 .

Multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic transplantation for high-risk multiple myeloma: Results of the BMT CTN 1302 Trial.

P. Hari, M. Pasquini, Q. Bashir, 2022, Transplantation and cellular therapy.

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2021, Blood advances.

Regulatory T cells: A review of manufacturing and clinical utility

J. Wagner, T. Mamo, Jeffrey S. Miller, 2022, Transfusion.

Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.

D. Weisdorf, N. Majhail, C. Brunstein, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors and outcomes of flares in chronic graft-versus-host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2020, Bone Marrow Transplantation.

Alternative Donor Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission: a CIBMTR-Eurocord Analysis

E. Gluckman, V. Rocha, X. Zhong, 2014 .

Alternative Donor Transplantation for Acute Myeloid Leukemia

N. Bejanyan, C. Brunstein, H. Haddad, 2015, Journal of clinical medicine.

Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia.

J. Wagner, D. Weisdorf, M. Verneris, 2012, Biology of Blood and Marrow Transplantation.

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2009, Blood.

with umbilical cord blood: safety profile and detection kinetics Infusion of ex vivo expanded T regulatory cells in adults transplanted

J. Wagner, B. Levine, C. June, 2011 .

Highly Variable Mycophenolate Mofetil Bioavailability Following Nonmyeloablative Hematopoietic Cell Transplantation

D. Weisdorf, P. Jacobson, T. DeFor, 2007, Journal of clinical pharmacology.

Umbilical cord blood: current status and future directions

D. McKenna, C. Brunstein, 2011, Vox sanguinis.

Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation

J. Wagner, G. Vercellotti, M. Verneris, 2014, Bone Marrow Transplantation.

preparative regimen for advanced Hodgkin lymphoma donor hematopoietic stem cell transplantation after reduced-intensity Comparable results of umbilical cord blood and HLA-matched sibling

J. Wagner, D. Weisdorf, T. DeFor, 2013 .

Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma.

J. Wagner, D. Weisdorf, T. DeFor, 2006, Blood.

Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation.

J. Wagner, M. Linden, M. Verneris, 2021, Transplantation and Cellular Therapy.

Prognostic factors for clinical outcomes of patients with central nervous system leukemia

D. Weisdorf, V. Bachanova, N. Bejanyan, 2020, Hematology/oncology and stem cell therapy.

OUTCOMES OF UCB TRANSPLANTATION ARE COMPARABLE IN FLT3+ AML: RESULTS OF CIBMTR, EUROCORD AND EBMT COLLABORATIVE ANALYSIS

F. Baron, B. Sandmaier, M. Labopin, 2016, Leukemia.

Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.

P. Parham, J. Wagner, Jeffrey S. Miller, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adaptive NK cell and KIR-expressing T cell responses are induced by CMV and are associated with protection against CMV reactivation after allogeneic donor hematopoietic cell transplantation Blood Marrow Transplant .

P. Parham, J. Wagner, D. Weisdorf, 2015 .

Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality.

D. Weisdorf, B. Blazar, T. DeFor, 2020, Blood advances.

Going straight to the point: intra-BM injection of hematopoietic progenitors

J. Wagner, P. Ramírez, C. Brunstein, 2010, Bone Marrow Transplantation.

CD34+ cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking.

J. Kurtzberg, E. Shpall, J. Kempenich, 2019, Blood advances.

Absence of early HHV‐6 reactivation after cord blood allograft predicts powerful graft‐versus‐tumor effect

Jeffrey S. Miller, D. Weisdorf, A. Rashidi, 2018, American journal of hematology.

Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression.

J. Wagner, C. Meisel, Jeffrey S. Miller, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prevention of GVHD by adoptive T regulatory therapy is associated with active repression of peripheral blood toll-like receptor-5 mRNA expression Biol Blood Marrow Transplant

C. Meisel, K. Vogt, B. Blazar, 2014 .

CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation

J. Wagner, C. Eide, D. Weisdorf, 2013, Leukemia.

Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host Disease

C. Brunstein, S. Holtan, Allison P Watson, 2018, Case reports in transplantation.

Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.

D. Weisdorf, M. Solh, S. Morgan, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center.

J. Wagner, H. Noreen, D. Kadidlo, 2009, Blood.

Umbilical cord blood transplantation.

J. Wagner, M. Laughlin, W. Tse, 2009, Cancer treatment and research.

A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation.

J. Wagner, Xiyan Xu, Jeffrey S. Miller, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Future of cord blood for oncology uses

D. Weisdorf, C. Brunstein, 2009, Bone Marrow Transplantation.

Umbilical cord blood transplantation for myeloid malignancies

J. Wagner, K. Baker, C. Brunstein, 2007, Current opinion in hematology.

Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for Lymphoma.

D. Weisdorf, M. Arora, A. Rashidi, 2021, Transplantation and cellular therapy.

graft-versus-leukemia effect in recipients of 2 units Relapse risk after umbilical cord blood transplantation: enhanced

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2013 .

COVID19 seroconversion in an unrelated stem cell donor

S. Devine, D. Weisdorf, M. Arora, 2020, Bone Marrow Transplantation.

Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ph‐like gene alterations and complex chromosomal abnormalities are frequent in patients with acute lymphoblastic leukemia experiencing relapse after allogeneic hematopoietic cell transplantation

S. Tracy, M. Meredith, B. Hirsch, 2022, European journal of haematology.

J. Wagner, T. Singleton, D. Weisdorf, 2013 .

J. Wagner, T. Singleton, D. Weisdorf, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

D. Kaufman, J. Wagner, K. Dusenbery, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Back to the future: mismatched unrelated donor, haploidentical related donor, or unrelated umbilical cord blood transplantation?

F. Aversa, C. Anasetti, C. Brunstein, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation.

J. Wagner, D. Weisdorf, M. Arora, 2019, Blood advances.

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units

J. Wagner, D. Weisdorf, J. Miller, 2009, Bone Marrow Transplantation.

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

J. Wingard, K. Ballen, Juan Wu, 2011, Blood.

Umbilical cord blood transplantation.

J. Wagner, M. Laughlin, W. Tse, 2009, Cancer treatment and research.

S. Debol, K. Nollet, T. Eastlund, 2002, Journal of clinical apheresis.

Second allogeneic hematopoietic cell transplantation for graft failure: Poor outcomes for neutropenic graft failure

J. Wagner, J. Tolar, D. Weisdorf, 2015, American journal of hematology.

Extending cord blood transplant to adults: dealing with problems and results overall.

M. Laughlin, C. Brunstein, 2010, Seminars in hematology.

Omidubicel Versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized Study.

O. Frankfurt, G. Schiller, P. Stiff, 2021, Blood.

Cord Blood Transplants Versus Other Sources of Allografts: Comparison of Data in Adult Setting

R. Mehta, C. Brunstein, 2017 .

Juan Wu, M. Eapen, E. Fuchs, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternative transplant donor sources: is there any consensus?

E. Fuchs, C. Brunstein, P. O'Donnell, 2013, Current opinion in oncology.

Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis.

M. Kirstein, V. Bachanova, P. Jacobson, 2022, Transplantation and cellular therapy.

Monosomal Karyotype Provides Better Prognostic Prediction After Allogeneic Stem Cell Transplantation in AML Patients.

D. Weisdorf, B. Oran, C. Brunstein, 2009 .

Minimal Residual Disease (MRD) Assessment before and after Autologous Hematopoietic Cell Transplantation (AutoHCT) and Maintenance for Multiple Myeloma (MM): Results of the Prognostic Immunophenotyping for Myeloma Response (PRIMeR) Study

N. Geller, A. Krishnan, P. Hari, 2019, Biology of Blood and Marrow Transplantation.

Hematology: ATG and Newton's third law of motion

C. Brunstein, 2010, Nature Reviews Clinical Oncology.

Adoptive Transfer of Umbilical Cord Blood (UCB)-Derived Regulatory T Cells (Tregs) to Recipients of Nonmyeloablative Unrelated Double UCB Transplantation.

J. Wagner, B. Levine, C. June, 2009 .

Hematopoietic Cell and Solid Organ Transplantation in the same patient: Long term experience at the University of Minnesota: Combined Hematopoietic and Solid Organ Transplantation.

T. Pruett, D. Weisdorf, T. DeFor, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.

R. Soiffer, M. Grunwald, N. Ghosh, 2021, Blood.

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

J. Wagner, B. Levine, C. June, 2011, Blood.

Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients

S. Bhatia, D. Weisdorf, M. Arora, 2022, Bone Marrow Transplantation.

Hematopoietic Cell Transplant Related Toxicities and Mortality in Frail Recipients.

S. Bhatia, D. Weisdorf, M. Arora, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Infectious complications following unrelated cord blood transplantation

J. V. van Burik, C. Brunstein, 2007, Vox sanguinis.

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2018, Blood advances.

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.

J. Wagner, J. Tolar, D. Weisdorf, 2006, Blood.

Cord blood transplantation for adults

J. Wagner, C. Brunstein, 2006, Vox sanguinis.

Umbilical cord blood transplantation and banking.

J. Wagner, C. Brunstein, J. Wagner, 2006, Annual review of medicine.

Expanding the role of umbilical cord blood transplantation

J. Wagner, C. Brunstein, D. Setubal, 2007, British journal of haematology.

Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.

J. Wagner, M. MacMillan, D. Weisdorf, 2009, Blood.

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.

J. Wagner, F. Appelbaum, K. Ballen, 2010, Blood.

Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.

J. Wagner, D. Weisdorf, T. DeFor, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2007, Blood.

Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type

D. Weisdorf, C. Cohn, T. DeFor, 2021, Transfusion.

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis

M. Horowitz, B. Shaw, S. Devine, 2020, Biology of Blood and Marrow Transplantation.

Evaluation of post‐thaw CFU‐GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant

J. Wagner, D. Sumstad, D. McKenna, 2019, Transfusion.

Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.

F. Gao, P. Westervelt, J. Dipersio, 2021, Blood.

CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT

J. Wagner, Bin Zhang, Jeffrey S. Miller, 2015, Leukemia.

Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type.

M. Robin, D. Weisdorf, G. Socié, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis Determined by Disease Risk Index.

D. Weisdorf, M. Arora, A. Rashidi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.

Jeffrey S. Miller, M. Verneris, V. Bachanova, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced Relapse and Similar Progression-Free Survival After Double Umbilical Cord Blood Transplantation (DUCBT): Comparison of Outcomes Between Sibling, Unrelated Adult and Unrelated DUCB Hematopoietic Stem Cell (HSC) Donors.

J. Wagner, F. Appelbaum, T. Gooley, 2009 .

Extramedullary blastic crisis in abdominal lymph nodes in a patient with chronic myelogenous leukemia on imatinib.

Z. Cayci, C. Ustun, C. Brunstein, 2012, Leukemia research.

Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.

J. Wagner, M. Mohty, P. Dreger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.

Avis J. Thomas, D. Kaufman, J. Wagner, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

Colleen Delaney, Claudio G Brunstein, Daniel J Weisdorf, 2010, Blood.

Guidelines for Cord Blood Unit Selection.

J. Wagner, E. Shpall, A. Scaradavou, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2008, Blood.

Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era

D. Weisdorf, V. Bachanova, Q. Cao, 2016, Bone Marrow Transplantation.

Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation

J. Wagner, G. Vercellotti, D. Weisdorf, 2013, Bone Marrow Transplantation.

Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms.

J. Wagner, M. Sanz, J. Sanz, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.

C. Le, J. Wagner, B. Levine, 2016, Blood.

Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft.

Jakub Tolar, Todd E DeFor, Claudio G Brunstein, 2016, Cell stem cell.

E. Leifer, M. Horowitz, Richard J. Jones, 2020, Blood.

Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2015, Blood.

Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies.

J. Wagner, Jeffrey S. Miller, R. Vogel, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Red blood cell product utilization in patients undergoing allogeneic stem cell transplantation

C. Cohn, R. Shanley, C. Brunstein, 2019, Transfusion.

Impact of long-term cryopreservation on single umbilical cord blood transplantation outcomes.

J. Wagner, M. Verneris, D. McKenna, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.

J. Wagner, J. Kurtzberg, E. Shpall, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Anti-HLA antibodies in double umbilical cord blood transplantation.

J. Wagner, Jeffrey S. Miller, H. Noreen, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation

N. Bejanyan, H. Elmariah, C. Brunstein, 2021, Life.

Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis BMT CTN 1101Open for Accrual June 2012Open for Accrual June 2012.

B. Logan, J. Magenau, C. Cutler, 2022, Transplantation and cellular therapy.

Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning

J. Wagner, K. Ballen, M. Verneris, 2021, Blood advances.

HLA Haploidentical versus Matched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide based prophylaxis.

R. Soiffer, M. Grunwald, N. Ghosh, 2021, Blood.

Umbilical cord blood or HLA-haploidentical transplantation: Real world outcomes vs randomized trial outcomes.

E. Leifer, Richard J. Jones, M. Grunwald, 2021, Transplantation and cellular therapy.

Clinical Relevance of Immunobiology in Umbilical Cord Blood Transplantation

M. J. Hussain, C. Brunstein, S. Nathan, 2019, Journal of clinical medicine.

Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.

J. Wagner, E. Shpall, L. Isola, 2013, Blood.

Factors Predicting Single-Unit Predominance after Double Umbilical Cord Blood Transplantation

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2011, Bone Marrow Transplantation.

Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

R. Porcher, M. Robin, P. Chevallier, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

E. Leifer, M. Horowitz, Richard J. Jones, 2021, Blood.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Therapeutic Cyclosporine Levels Early Post-Transplantation Reduces Risks of Acute Graft-Versus-Host Disease and Improves Survival

D. Weisdorf, B. Blazar, M. Arora, 2013, Bone Marrow Transplantation.

Guidelines for Infection Prophylaxis, Monitoring and Therapy in Cord Blood Transplantation.

C. Brunstein, A. Olson, J. Barker, 2021, Transplantation and cellular therapy.

Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.

J. Wagner, Priya Kumar, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2018, Haematologica.

The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia

M. Perales, M. Territo, D. Weisdorf, 2017, Haematologica.

M. Perales, F. Appelbaum, J. Pidala, 2014, Haematologica.

Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts.

J. Wagner, K. Ballen, R. Soiffer, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2010 .

The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML

J. Wagner, D. Weisdorf, T. DeFor, 2014, Bone Marrow Transplantation.

Herpes simplex virus encephalitis after allogeneic transplantation: an instructive case

D. Weisdorf, N. Majhail, R. Romee, 2010, Bone Marrow Transplantation.

Complement fragment 3a priming of umbilical cord blood progenitors: safety profile.

J. Wagner, M. Ratajczak, D. Weisdorf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Planned granulocyte-colony stimulating factor adversely impacts survival after allogeneic hematopoietic cell transplantation performed with Thymoglobulin for myeloid malignancy.

M. Grunwald, O. Ringdén, H. Lazarus, 2021, Transplantation and cellular therapy.

Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.

N. Geller, A. Krishnan, R. Vij, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis

D. Blaise, M. Horowitz, M. Flowers, 2016, Bone Marrow Transplantation.

Association of CD34 cell dose with 5-year overall survival after peripheral blood allogeneic hematopoietic cell transplantation in adults with hematologic malignancies.

M. Arora, V. Bachanova, Q. Cao, 2021, Transplantation and cellular therapy.

Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants.

C. Le, J. Wagner, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

6: Risk of Relapse after Umbilical Cord Blood Transplantation in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006 .

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

C. Le, K. Dusenbery, Jeffrey S. Miller, 2006 .

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2010, Bone Marrow Transplantation.

Low 5-year health care burden after umbilical cord blood transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2021, Blood advances.

The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2016, Current topics in microbiology and immunology.

Reduced Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor.

Avis J. Thomas, D. Kaufman, J. Wagner, 2007 .

Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia.

M. Linden, D. Weisdorf, N. Bejanyan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation.

J. Wagner, J. Miller, I. Vlasova-St Louis, 2021, Transplantation and cellular therapy.

Changing Trends of Unrelated Umbilical Cord Blood Transplantation for Hematologic Diseases in Patients Older than Fifty Years: A Eurocord-Center for International Blood and Marrow Transplant Research Survey.

D. Weisdorf, E. Gluckman, M. Eapen, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors

J. Wagner, D. Weisdorf, N. Majhail, 2012, Bone Marrow Transplantation.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Faculty of 1000 evaluation for Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.

C. Brunstein, 2011 .

Donor‐derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response

J. Wagner, T. DeFor, A. Dietz, 2014, British journal of haematology.

Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

K. Dusenbery, D. Weisdorf, M. Verneris, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation

J. Wagner, P. Jacobson, T. DeFor, 2009, Bone Marrow Transplantation.

Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.

D. Weisdorf, M. Verneris, V. Bachanova, 2009, Blood.

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation

M. Linden, A. Rashidi, J. Miller, 2018, Bone Marrow Transplantation.

Immune Reconstitution after Umbilical Cord Blood Versus Peripheral Blood Progenitor Cell Transplantation in Adults Following Myeloablative Conditioning

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2016 .

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD

J. Wagner, D. Weisdorf, M. Verneris, 2016, Haematologica.

Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma.

P. Riedell, Sonali M. Smith, F. Locke, 2021, Transplantation and cellular therapy.

High Proliferating Regulatory T cells Post-transplant are Associated with Poor Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation: Regulatory T cells and Autologous Hematopoietic Stem Cell Transplantation in Lymphoma.

V. Bachanova, Q. Cao, C. Brunstein, 2022, Transplantation and cellular therapy.

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

S. Bhatia, G. Vercellotti, M. MacMillan, 2021, Blood Cancer Journal.

Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplant

J. Wagner, M. MacMillan, D. Weisdorf, 2014, Leukemia & lymphoma.

Adaptive NK cell reconstitution is associated with better clinical outcomes.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2019, JCI insight.

The biology and treatment of chronic myelogenous leukemia.

C. Brunstein, P. Mcglave, 2001, Oncology.

Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma: Long-term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial.

N. Geller, A. Krishnan, P. Hari, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

transplantation reduced-intensity conditioning with cord blood or sibling donor Prolonged survival in adults with acute lymphoblastic leukemia after

D. Weisdorf, M. Verneris, V. Bachanova, 2013 .

Prolonged Survival In Adults With Acute Lymphoblastic Leukemia (ALL) Following Reduced Intensity Conditioning With Cord Blood or Sibling Donor Transplantation

D. Weisdorf, M. Verneris, V. Bachanova, 2009 .

Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.

M. Pasquini, J. Wingard, K. Ballen, 2019, Blood advances.

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

J. Wagner, M. MacMillan, D. Weisdorf, 2021, Bone Marrow Transplantation.

R. Porcher, M. Robin, P. Chevallier, 2012 .

Reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: related donor and umbilical cord allografting

R. Vogel, D. Weisdorf, V. Bachanova, 2012, British journal of haematology.

Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival

M. Reding, D. Weisdorf, M. Reding, 2015, Bone Marrow Transplantation.

Prophylactic foscarnet for human herpesvirus 6: effect on hematopoietic engraftment after reduced intensity conditioning umbilical cord blood transplantation.

J. Wagner, D. Weisdorf, M. Arora, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Weight‐based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation

J. Wagner, M. MacMillan, D. Weisdorf, 2018 .

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

M. Robin, M. MacMillan, D. Weisdorf, 2016, Haematologica.

G. Vercellotti, M. Arora, V. Bachanova, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Wanted: prospective studies of alternative donors.

C. Brunstein, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

M. Pasquini, J. Wingard, K. Ballen, 2018, Blood.

Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation

J. Vose, P. Riedell, Sonali M. Smith, 2021, British journal of haematology.

A modified comorbidity index for hematopoietic cell transplantation

C. Le, D. Weisdorf, M. Arora, 2010, Bone Marrow Transplantation.

Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients

D. Weisdorf, M. Arora, V. Bachanova, 2014, American journal of hematology.

Adoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord blood.

P. Hanley, C. Bollard, C. Brunstein, 2015, Cytotherapy.

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor.

J. Wagner, Chi Chen, G. Vercellotti, 2020, Blood advances.

Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes: Comparable Outcomes With Unrelated Umbilical Cord Blood and HLA-Identical Sibling Donors

J. Wagner, D. Weisdorf, N. Majhail, 2011 .

Impact of Delayed Infusion Time in Umbilical Cord Blood Transplantation.

M. Verneris, D. McKenna, R. Mitchell, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In the end, there can be only one … cord blood unit.

C. Brunstein, 2016, Blood.

Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma

N. Geller, A. Krishnan, P. Hari, 2022, American journal of hematology.

Yan Song, A. Sung, W. Hwang, 2022, Transplantation and cellular therapy.

Fludarabine Pharmacokinetics in Nonmyeloablative Hematopoietic Cell Transplantation (HCT): Association with Engraftment and Neurotoxicty.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2005 .

Pilot Phase II Study of Gemcitabine and Vinorelbine in Patients with Recurrent or Refractory Small Cell Lung Cancer

R. Kratzke, R. Bliss, A. Dudek, 2004, Lung.

B. Logan, Sanghee Hong, B. Hamilton, 2023, Transplantation and cellular therapy.

Mixed vs full donor engraftment early after hematopoietic cell transplant: Impact on incidence and control of cytomegalovirus infection

M. Verneris, Jo-Anne H. Young, R. Shanley, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

The Bone Marrow Microenvironment

C. Verfaillie, C. Brunstein, 2004 .

Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.

J. Kurtzberg, O. Frankfurt, D. Cilloni, 2023, Transplantation and cellular therapy.

Analysis of the CD34+ Cell Content of 126, 341 Cord Blood (CB) Units in the NMDP be the Match Inventory: Implications for CB Transplantation and Public Banking

J. Kurtzberg, E. Shpall, J. Kempenich, 2018 .

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS).

J. Wagner, Priya Kumar, Jeffrey S. Miller, 2005 .

Comparison of Outcomes After Unrelated Cord Blood Transplantation and Matched Unrelated Donor RIC Transplantation for Lymphoid Malignancies - A Eurocord-Netcord Group/ Lymphoma Working Party and Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Study.

J. Wagner, J. Finke, D. Blaise, 2009 .

Favorable Leukemia-Free Survival (LFS) for Adults and Children Undergoing Myeloablative Umbilical Cord Blood (UCB) Transplantation with Cyclophosphamide (CY), Fludarabine (FLU) and Total Body Irradiation (TBI): A Single Center Analysis of 194 Patients

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2009 .

Umbilical Cord Blood Transplant after Reduced Intensity Conditioning Provides Outcomes Comparable HLA-Matched Siblings for Patients with High Risk and Advanced Acute Myeloid Leukemia.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006 .

Umbilical cord blood transplantation.

J Wagner, W. Tse, J. Warner, 2009, Cancer treatment and research.

High Thyroglobulin Antibody Following Intravenous Immunoglobulin Therapy in Athyreotic Differentiated Thyroid Cancer Patients

L. Burmeister, C. Brunstein, Gurunanthan Palani, 2022, Cureus.

StemRegenin-1 (SR1) Expansion Culture Abrogates the Engraftment Barrier Associated with Umbilical Cord Blood Transplantation (UCBT)

Anthony E. Boitano, J. Wagner, M. Cooke, 2014 .

Harvest Quality, Nucleated Cell Dose and Clinical Outcomes in Bone Marrow Transplantation: A Retrospective Study.

M. MacMillan, D. Sumstad, D. McKenna, 2022, Transplantation and Cellular Therapy.

Chromosomal Translocations in Hematologic Malignancies

C. Verfaillie, S. Dylla, C. Brunstein, 2002 .

Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture

Anthony E. Boitano, J. Wagner, M. Cooke, 2015 .

Safety and Exploratory Efficacy Of Ex Vivo Expanded Umbilical Cord Blood (UCB) Hematopoietic Stem and Progenitor Cells (HSPC) Using Cytokines and Stem-Regenin 1 (SR1): Interim Results Of a Phase 1/2 Dose Escalation Clinical Study

Anthony E. Boitano, M. Cooke, C. Bleul, 2013 .

The biology and treatment of chronic myelogenous leukemia.

C. Brunstein, P. Mcglave, 2001, Oncology.

Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.

J. Wagner, Jeffrey S. Miller, M. Verneris, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome.

D. Weisdorf, V. Bachanova, L. Burns, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival

C. Brunstein, D. Weisdorf, C. Brunstein, 2011, Bone Marrow Transplantation.

Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation.

D. Weisdorf, A. Blaes, Jo-Anne H. Young, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patients

V. Bachanova, P. Jacobson, Takuto Takahashi, 2022, Cancer Chemotherapy and Pharmacology.

Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic Malignancy

D. Weisdorf, V. Bachanova, P. Jacobson, 2021 .

Non-Myeloablative (NMA) Umbilical Cord Blood Transplantation (UCBT): Promising Disease-Free Survival in 95 Consecutive Patients.

D. Weisdorf, C. Brunstein, J. Barker, 2005 .

Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.

E. Shpall, L. Isola, N. Chao, 2013, Blood.

Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced Intensity Hematopoietic Cell Transplant for Adult Hematologic Malignancy.

D. Weisdorf, V. Bachanova, P. Jacobson, 2021, Transplantation and cellular therapy.

Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.

M. Norkin, M. Perales, S. Mineishi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mgta-456, an Aryl Hydrocarbon Receptor (AHR) Antagonist Based Expansion of CD34+ Hematopoietic Stem Cells (HSC), Permits Selection of Better HLA Matched Cord Blood Units (CBUs) and Promotes Faster Neutrophil Recovery and Uniform Engraftment with Potentially Less Acute Graft-Vs-Host Disease (GVHD)

Anthony E. Boitano, M. Cooke, John C. Davis, 2019, Blood.